Invivo’s DynaTRIM system is the first commercially available, fully magnetic resonance imaging (MRI)-compatible interventional device for transrectal interventional MRI of the prostate gland.
Pairing DynaCAD for Prostate with DynaTRIM enables a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy.
For more information: www.invivocorp.com
September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
September 27, 2023 
September 27, 2023 — The American Society for Radiation Oncology (ASTRO) announced the three winning research proposals ...
September 27, 2023 
September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...
September 27, 2023 
Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...
September 25, 2023 
September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...
September 22, 2023 
September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of ...
September 21, 2023 
In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...
September 19, 2023 
The world of medical imaging is marking a significant milestone in 2023: the 50th anniversary of magnetic resonance ...
September 19, 2023 
September 13, 2023 — Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients ...
September 13, 2023 
September 12, 2023 — Michael J. Zelefsky, MD, a renowned leader in radiation oncology, is joining NYU Langone’s ...
September 12, 2023